Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Other-Operating-Expenses" stands at 134.94 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 12/31/2012.
Kyowa Kirin Co Ltd's second quarter result of 40.78 Billion JPY for the item "Other Operating Expenses" represents a decrease of -3.00 percent compared to it's first quarter result.
Also, Kyowa Kirin Co Ltd's second quarter result of 40.78 Billion JPY for the item "Other Operating Expenses" represents an increase of 781.32 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Kyowa Kirin Co Ltd's second quarter result of 134.94 Billion JPY for the item "Other Operating Expenses" represents an increase of 53.04 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 149.67 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 149.67 Billion Japanese Yens.
The 3 year change is 142.12 Billion Japanese Yens.
The 5 year change is 124.33 Billion Japanese Yens.
The 10 year change is 29.41 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Operating Expenses | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Operating Expenses | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Operating Expenses | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Operating Expenses | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Operating Expenses | 280,205,508,085.11 |